Annual Revenue
$448.27 M
-$1.04 B-69.97%
01 December 2023
Summary:
Sinovac Biotech annual revenue is currently $448.27 million, with the most recent change of -$1.04 billion (-69.97%) on 01 December 2023. During the last 3 years, it has fallen by -$62.35 million (-12.21%). SVA annual revenue is now -97.69% below its all-time high of $19.37 billion, reached on 31 December 2021.SVA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly revenue is not available.SVA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
01 June 2024
Summary:
Sinovac Biotech TTM revenue is not available.SVA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -12.2% | - | - |
| 5 y5 years | +95.2% | - | - |
SVA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -97.7% | at low | ||||
| 5 y | 5 years | -97.7% | +95.2% | ||||
| alltime | all time | -97.7% | >+9999.0% |
Sinovac Biotech Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $448.27 M(-70.0%) | - | - |
| Dec 2022 | $1.49 B(-92.3%) | - | - |
| Dec 2021 | $19.37 B(+3694.4%) | - | - |
| Dec 2020 | $510.62 M(+107.5%) | $327.45 M(+183.6%) | $510.62 M(+93.2%) |
| Sept 2020 | - | $115.45 M(+120.6%) | $264.28 M(+24.0%) |
| June 2020 | - | $52.33 M(+240.0%) | $213.17 M(-5.2%) |
| Mar 2020 | - | $15.39 M(-81.0%) | $224.89 M(-8.6%) |
| Dec 2019 | $246.05 M(+7.1%) | $81.11 M(+26.1%) | $246.05 M(+12.8%) |
| Sept 2019 | - | $64.34 M(+0.5%) | $218.15 M(+5.0%) |
| June 2019 | - | $64.05 M(+75.2%) | $207.76 M(-5.1%) |
| Mar 2019 | - | $36.55 M(-31.3%) | $218.87 M(-4.7%) |
| Dec 2018 | $229.65 M(+31.7%) | $53.21 M(-1.4%) | $229.65 M(+30.2%) |
| Sept 2018 | - | $53.95 M(-28.2%) | $176.44 M(+44.0%) |
| June 2018 | - | $75.15 M(+58.8%) | $122.49 M(+158.8%) |
| Mar 2018 | - | $47.34 M(+50.9%) | $47.34 M(-34.6%) |
| Dec 2017 | $174.35 M(+140.7%) | - | - |
| Dec 2016 | $72.43 M(+7.4%) | $31.36 M(+9.2%) | $72.43 M(+13.1%) |
| Sept 2016 | - | $28.73 M(+1986.8%) | $64.02 M(+23.0%) |
| June 2016 | - | $1.38 M(-87.4%) | $52.05 M(-24.7%) |
| Mar 2016 | - | $10.95 M(-52.3%) | $69.16 M(+2.6%) |
| Dec 2015 | $67.41 M(+7.1%) | $22.95 M(+36.9%) | $67.41 M(+4.3%) |
| Sept 2015 | - | $16.76 M(-9.3%) | $64.61 M(-0.6%) |
| June 2015 | - | $18.49 M(+100.8%) | $64.99 M(+10.9%) |
| Mar 2015 | - | $9.21 M(-54.3%) | $58.59 M(-6.9%) |
| Dec 2014 | $62.93 M(-12.3%) | $20.15 M(+17.5%) | $62.93 M(-3.1%) |
| Sept 2014 | - | $17.15 M(+41.8%) | $64.98 M(-7.1%) |
| June 2014 | - | $12.09 M(-10.7%) | $69.91 M(-7.1%) |
| Mar 2014 | - | $13.55 M(-39.0%) | $75.27 M(+4.9%) |
| Dec 2013 | $71.77 M(+45.8%) | $22.20 M(+0.5%) | $71.77 M(+3.8%) |
| Sept 2013 | - | $22.07 M(+26.5%) | $69.17 M(+12.7%) |
| June 2013 | - | $17.45 M(+73.6%) | $61.38 M(+15.2%) |
| Mar 2013 | - | $10.05 M(-48.7%) | $53.29 M(+8.3%) |
| Dec 2012 | $49.22 M(-13.4%) | $19.59 M(+37.1%) | $49.22 M(-3.1%) |
| Sept 2012 | - | $14.29 M(+52.6%) | $50.77 M(-2.1%) |
| June 2012 | - | $9.36 M(+56.8%) | $51.84 M(-10.8%) |
| Mar 2012 | - | $5.97 M(-71.7%) | $58.13 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $56.84 M(+70.2%) | $21.14 M(+37.6%) | $56.74 M(+26.8%) |
| Sept 2011 | - | $15.36 M(-1.9%) | $44.74 M(+14.9%) |
| June 2011 | - | $15.66 M(+241.6%) | $38.93 M(+16.1%) |
| Mar 2011 | - | $4.58 M(-49.9%) | $33.54 M(+0.4%) |
| Dec 2010 | $33.40 M(-60.3%) | $9.14 M(-4.3%) | $33.40 M(-44.9%) |
| Sept 2010 | - | $9.55 M(-6.9%) | $60.65 M(-16.1%) |
| June 2010 | - | $10.26 M(+131.0%) | $72.32 M(-11.9%) |
| Mar 2010 | - | $4.44 M(-87.8%) | $82.08 M(-2.5%) |
| Dec 2009 | $84.20 M(+81.1%) | $36.39 M(+71.4%) | $84.20 M(+39.9%) |
| Sept 2009 | - | $21.22 M(+6.0%) | $60.17 M(+26.1%) |
| June 2009 | - | $20.02 M(+204.9%) | $47.70 M(+7.9%) |
| Mar 2009 | - | $6.57 M(-46.9%) | $44.20 M(-4.9%) |
| Dec 2008 | $46.50 M(+38.6%) | $12.36 M(+41.2%) | $46.50 M(+7.3%) |
| Sept 2008 | - | $8.75 M(-47.0%) | $43.34 M(-4.6%) |
| June 2008 | - | $16.52 M(+86.4%) | $45.41 M(+27.4%) |
| Mar 2008 | - | $8.86 M(-3.7%) | $35.65 M(+7.9%) |
| Dec 2007 | $33.54 M(+118.4%) | $9.20 M(-15.0%) | $33.04 M(+19.4%) |
| Sept 2007 | - | $10.83 M(+60.3%) | $27.68 M(+33.8%) |
| June 2007 | - | $6.76 M(+8.0%) | $20.69 M(+27.1%) |
| Mar 2007 | - | $6.26 M(+63.0%) | $16.27 M(+31.7%) |
| Dec 2006 | $15.35 M(+78.4%) | $3.84 M(0.0%) | $12.35 M(+7.7%) |
| Sept 2006 | - | $3.84 M(+64.2%) | $11.47 M(+8.4%) |
| June 2006 | - | $2.34 M(0.0%) | $10.59 M(+10.3%) |
| Mar 2006 | - | $2.34 M(-20.9%) | $9.60 M(+11.5%) |
| Dec 2005 | $8.61 M(+33.4%) | $2.95 M(0.0%) | $8.61 M(+0.8%) |
| Sept 2005 | - | $2.95 M(+119.0%) | $8.54 M(+24.4%) |
| June 2005 | - | $1.35 M(0.0%) | $6.86 M(+3.1%) |
| Mar 2005 | - | $1.35 M(-53.2%) | $6.66 M(+3.2%) |
| Dec 2004 | $6.45 M(+127.3%) | $2.88 M(+125.3%) | $6.45 M(+752.6%) |
| Sept 2004 | - | $1.28 M(+11.7%) | $757.00 K(-68.9%) |
| June 2004 | - | $1.15 M(0.0%) | $2.43 M(+89.1%) |
| Mar 2004 | - | $1.15 M(-140.7%) | $1.29 M(+816.1%) |
| Dec 2003 | $2.84 M(+446.8%) | -$2.81 M(-195.2%) | $140.40 K(-95.2%) |
| Sept 2003 | - | $2.95 M | $2.95 M |
| Apr 2002 | $519.20 K(+63.0%) | - | - |
| Apr 2001 | $318.50 K(>+9900.0%) | - | - |
| Apr 2000 | $1400.00 | - | - |
FAQ
- What is Sinovac Biotech annual revenue?
- What is the all time high annual revenue for Sinovac Biotech?
- What is the all time high quarterly revenue for Sinovac Biotech?
- What is the all time high TTM revenue for Sinovac Biotech?
What is Sinovac Biotech annual revenue?
The current annual revenue of SVA is $448.27 M
What is the all time high annual revenue for Sinovac Biotech?
Sinovac Biotech all-time high annual revenue is $19.37 B
What is the all time high quarterly revenue for Sinovac Biotech?
Sinovac Biotech all-time high quarterly revenue is $327.45 M
What is the all time high TTM revenue for Sinovac Biotech?
Sinovac Biotech all-time high TTM revenue is $510.62 M